🎙️ We’re back with the sixteenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem. In this episode, Bas discusses the Article of the Week: Mucuna pruriens in untreated Parkinson’s disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial. He explores the study’s design, key findings, and what this important research tells us about alternative, accessible treatment options for Parkinson’s disease, particularly in under-resourced settings, as well as its broader...
All content for Parkinson Weekly is the property of Oruen CNS and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
🎙️ We’re back with the sixteenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem. In this episode, Bas discusses the Article of the Week: Mucuna pruriens in untreated Parkinson’s disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial. He explores the study’s design, key findings, and what this important research tells us about alternative, accessible treatment options for Parkinson’s disease, particularly in under-resourced settings, as well as its broader...
EP 14 - Artificial intelligence — Great Promises & Great Concerns
Parkinson Weekly
7 minutes
1 month ago
EP 14 - Artificial intelligence — Great Promises & Great Concerns
🎙️ We’re back with the fourteenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem. In this week’s episode, Bas delves into the rapidly evolving world of artificial intelligence and its growing influence on Parkinson’s disease care and healthcare in general. He explores how AI-driven tools offer remarkable new possibilities — from earlier diagnosis to personalised treatment strategies — while also highlighting the ethical, clinical, and practical concerns that come with relying on algor...
Parkinson Weekly
🎙️ We’re back with the sixteenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem. In this episode, Bas discusses the Article of the Week: Mucuna pruriens in untreated Parkinson’s disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial. He explores the study’s design, key findings, and what this important research tells us about alternative, accessible treatment options for Parkinson’s disease, particularly in under-resourced settings, as well as its broader...
